USA - NASDAQ:NSTG - US63009R1095 - Common Stock
The current stock price of NSTG is 0.1053 USD. In the past month the price decreased by -74.34%. In the past year, price decreased by -99.03%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 25.34 | 214.35B | ||
| DHR | DANAHER CORP | 27.52 | 151.95B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 160.81 | 48.80B | ||
| A | AGILENT TECHNOLOGIES INC | 26.93 | 41.61B | ||
| IQV | IQVIA HOLDINGS INC | 18.07 | 35.72B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 35.2 | 29.66B | ||
| WAT | WATERS CORP | 29.29 | 22.14B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 40.1 | 20.39B | ||
| ILMN | ILLUMINA INC | 28.08 | 18.82B | ||
| MEDP | MEDPACE HOLDINGS INC | 41.87 | 16.82B | ||
| TEM | TEMPUS AI INC | N/A | 14.29B | ||
| ICLR | ICON PLC | 12.41 | 12.73B |
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 703 full-time employees. The company went IPO on 2013-06-26. The company develops, manufactures, and markets technologies of biological materials for life science researchers in the fields of genomics and proteomics. Its product platforms include nCounter Analysis System (nCounter), CosMx Spatial Molecular Imager, AtoMx Spatial Informatics Platform, and GeoMx Digital Spatial Profiler (GeoMx DSP). Its nCounter is a multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. Its nCounter platform is based on automated instruments that prepare and analyze biological samples using reagents. GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. Its CosMx Spatial Molecular Imager is a spatial biology product platform.
NANOSTRING TECHNOLOGIES INC
530 Fairview Avenue North
Seattle WASHINGTON 98109 US
CEO: R. Bradley Gray
Employees: 703
Phone: 12063786266
NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. The company is headquartered in Seattle, Washington and currently employs 703 full-time employees. The company went IPO on 2013-06-26. The company develops, manufactures, and markets technologies of biological materials for life science researchers in the fields of genomics and proteomics. Its product platforms include nCounter Analysis System (nCounter), CosMx Spatial Molecular Imager, AtoMx Spatial Informatics Platform, and GeoMx Digital Spatial Profiler (GeoMx DSP). Its nCounter is a multi-application, digital detection and counting system which directly profiles hundreds of molecules simultaneously, using optical barcoding chemistry. Its nCounter platform is based on automated instruments that prepare and analyze biological samples using reagents. GeoMx DSP is used to analyze selected regions of an intact biological sample without the need to break down the sample, enabling researchers to see how gene expression might vary across those regions. Its CosMx Spatial Molecular Imager is a spatial biology product platform.
The current stock price of NSTG is 0.1053 USD. The price decreased by -37.43% in the last trading session.
NSTG does not pay a dividend.
NSTG has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
NSTG stock is listed on the Nasdaq exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NSTG.
ChartMill assigns a fundamental rating of 2 / 10 to NSTG. NSTG has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NSTG reported a non-GAAP Earnings per Share(EPS) of -3.53. The EPS decreased by -12.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -60.59% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
13 analysts have analysed NSTG and the average price target is 2.07 USD. This implies a price increase of 1866.38% is expected in the next year compared to the current price of 0.1053.
For the next year, analysts expect an EPS growth of 4.9% and a revenue growth 40.02% for NSTG